Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [1]. - As a result of these issues, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company reportedly faced insufficient liquidity, and the defendants' positive statements regarding the company's business and prospects were misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for the allegations spans from November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle, and there is no cost or obligation to participate [2]. Group 3: Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against ModivCare, Inc. due to alleged violations of federal securities laws, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is urging investors who suffered losses exceeding $50,000 in ModivCare between November 3, 2022, and May 3, 2023, to discuss their legal options [1]. - A federal securities class action has been filed against ModivCare, with a deadline of March 31, 2025, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that ModivCare and its executives made false or misleading statements regarding the company's financial health, including issues with contract renegotiations and liquidity [4]. Group 2: Financial Impact and Stock Performance - Following the revelation of ModivCare's financial issues, the company's stock price experienced a significant decline, dropping nearly 10% from $14.12 to $12.72 per share on September 16, 2024, after a negative financial update [5]. - The company revised its 2024 Adjusted EBITDA guidance from a range of $185-$195 million to $170-$180 million, primarily due to pricing accommodations in the NEMT segment [5]. Group 3: Firm Background and Contact Information - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in multiple states [3]. - The firm encourages anyone with information regarding ModivCare's conduct, including whistleblowers and former employees, to reach out [7].

NEW YORK, March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV).Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/modivcare-inc-loss-submission-form/?id=135475&from=4CLASS PERIOD: November 3, 2022 to Sep ...

NEW YORK, March 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/modivcare-inc-lawsuit-subm ...

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022 and September 15, 2024. ModivCare provides a suite of integrated supportive care solutions for public and private payors and their members. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: R ...

NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV).Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/modivcare-inc-loss-submission-form/?id=134593&from=4CLASS PERIOD: November 3, 2022 to Sep ...

ModivCare Inc. (NASDAQ:MODV) Q4 2024 Earnings Conference Call March 6, 2025 5:00 PM ET Company Participants Heath Sampson – President and Chief Executive Officer Barbara Gutierrez – Chief Financial Officer Conference Call Participants Megan Holton – Jefferies Pito Chickering – Deutsche Bank Lee Jagoda – CJS Securities Raj Kumar – Stephens Operator Good day, everyone. And welcome to ModivCare Inc.'s Fourth Quarter and Full Year 2024 Finance Results Conference Call. At this time, all participants are in a lis ...

ModivCare (MODV) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to earnings of $1.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 290%. A quarter ago, it was expected that this provider of government-sponsored social services would post earnings of $0.59 per share when it actually produced earnings of $0.45, delivering a surprise of -23.7 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of incor ...

Exhibit 10.1 AMENDMENT NO. 5 Dated as of January 9, 2025 to CREDIT AGREEMENT Dated as of February 3, 2022 THIS AMENDMENT NO. 5 (this "Amendment") is made as of January 9, 2025, by and among ModivCare Inc., a corporation organized under the laws of the State of Delaware (the "Borrower"), the financial institutions listed on the signature pages hereof and JPMorgan ChaseBank, N.A., as administrative agent (the "Administrative Agent"), under that certain Credit Agreement, dated as of February 3, 2022, by and am ...